By CNBC-TV18 Feb 12, 2019 5:07:37 PM IST (Updated)
Follow real-time updates on Union Budget 2023Catch exclusive videos on Union Budget 2023 from CNBC-TV18
Sun Pharmaceutical on Tuesday reported a 286.1 percent year-on-year (YoY) jump in consolidated net profit at Rs 1,241.8 crore for the December 2018 quarter.
Pharma major, Sun Pharmaceutical Industries, on Tuesday reported a 286.1 percent year-on-year (YoY) jump in consolidated net profit at Rs 1,241.8 crore for the December 2018 quarter.
Recommended Articles
View All
Budget 2023: Taking a bold step to unlock India’s potential
Feb 2, 2023 IST2 Min(s) Read
Budget 2023: Moving closer towards universal health through proper implementation is key
Feb 2, 2023 IST3 Min(s) Read
Explained: Pakistan economy on the edge of collapse — why India may be worried
Feb 2, 2023 IST10 Min(s) Read
Budget 2023: Unleashing India’s growth potential in the years to come
Feb 2, 2023 IST2 Min(s) Read
In the corresponding quarter last year, the company posted a net profit of Rs 321 crore.
CNBC-TV18 Polls had predicted a profit of Rs 1,064 crore for the quarter under review.
Consolidated total revenue increased 16.3 percent year-on-year to Rs 7,740.2 crore during the quarter under review against Rs 6,653.2 crore in the same period last year.
Consolidated earnings before interest, taxes, depreciation, and amortization (EBITDA) rose to Rs 2,153 crore during the quarter under review against Rs 1,453 crore last year.
Shares of Sun Pharma settled at Rs 436.75 apiece, up 2 percent on the BSE.
First Published: Feb 12, 2019 4:43 PM IST
Check out our in-depth Market Coverage, Business News & get real-time Stock Market Updates on CNBC-TV18. Also, Watch our channels CNBC-TV18, CNBC Awaaz and CNBC Bajar Live on-the-go!